000 | 01529 a2200469 4500 | ||
---|---|---|---|
005 | 20250514072121.0 | ||
264 | 0 | _c20030731 | |
008 | 200307s 0 0 eng d | ||
022 | _a0250-7005 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHoopmann, Markus | |
245 | 0 | 0 |
_aHER-2/neu determination in blood plasma of patients with HER-2/neu overexpressing metastasized breast cancer: a longitudinal study. _h[electronic resource] |
260 |
_bAnticancer research _c |
||
300 |
_a1031-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 |
_aBreast Neoplasms _xpathology |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aReagent Kits, Diagnostic |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xblood |
650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTrastuzumab |
700 | 1 | _aNeumann, Rainer | |
700 | 1 | _aTanasale, Thérese | |
700 | 1 | _aSchöndorf, Thomas | |
773 | 0 |
_tAnticancer research _gvol. 23 _gno. 2A _gp. 1031-4 |
|
999 |
_c12603667 _d12603667 |